Close Menu

In a recent post, blogger Biochem Belle of There and (Hopefully) Back Again shares her "decision to be less restrictive in my job search than I was a couple of years ago and to apply for both academic (postdoc) and industry positions." A choice that she says means, "among other things, having two versions of my CV." In drafting two versions of the same document — an "industry CV" as well as a "traditional" one — the blogger says she's discovered that "academics care about your pedigree and publicat

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.